A snippet of good news regarding the efficacy of Aroas OviTex hernia repair products.
Tela Bio the company that distributes Aroas OviTex products in USA, presented the results of two studies at the American Hernia Society over the weekend. (yes there is such a society) The studies showed clinical evidence that their product offered high safety and very low recurrence rates.
The outlook for this product is good based on the surgical results and the low cost of the product, potentially leading to increase in market penetration for the products.
Come on finish 1.60 plus, page-104
Add ARX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
62.5¢ |
Change
-0.015(2.34%) |
Mkt cap ! $215.1M | |||
| Open | High | Low | Value | Volume |
| 64.5¢ | 64.5¢ | 62.0¢ | $47.64K | 76.21K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1699 | 61.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 62.5¢ | 309 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
62.0¢ |
Change
-0.015 ( 1.59 %) |
||||
| Open | High | Low | Volume | ||
| 63.0¢ | 63.0¢ | 62.0¢ | 33827 | ||
| Last updated 15.14pm 14/06/2024 ? | |||||
| ARX (ASX) Chart |